Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$36.71

-1.61 (-4.20%)

16:23
11/06/18
11/06
16:23
11/06/18
16:23

Myriad Genetics sees FY19 adj. EPS $1.70-$1.75, consensus $1.72

Sees FY19 revenue $855M-$865M, consensus $887.98M.

  • 06

    Nov

  • 06

    Nov

  • 14

    Nov

MYGN Myriad Genetics
$36.71

-1.61 (-4.20%)

10/10/18
PIPR
10/10/18
UPGRADE
Target $53
PIPR
Overweight
Myriad Genetics upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst William Quirk upgraded Myriad Genetics to Overweight and raised his price target for the shares to $53 from $38. After updating his reimbursement model for Myriad's Prolaris, Vectra, and GeneSight, the analyst believes the company has $9 of earnings per share power. Quirk now has increased confidence in Myriad's ability to beat Street expectations and admits he's been wrong on the shares.
11/01/18
PIPR
11/01/18
NO CHANGE
Target $53
PIPR
Overweight
Myriad Genetics should be bought on weakness, says Piper Jaffray
Piper Jaffray analyst William Quirk notes that Myriad Genetics' shares are off about 15% on two items, neither of which he believes will have a lasting effect on the company's business. First is an FDA safety communication about genetics tests used to predict drug response, he points out, adding that the letter "has teeth," but likely for consumer-oriented tests. The second is the 23&Me approval for a consumer-based pharmacogenomics test, which could certainly open up more testing, but within the consumer-driven, not physician-driven channel, he argues. Accordingly, Quirk recommends buying shares on the pullback, and reiterates an Overweight rating and $53 price target on the stock.
11/01/18
MSCO
11/01/18
NO CHANGE
MSCO
Myriad Genetics shares defended at Morgan Stanley
11/01/18
MSCO
11/01/18
NO CHANGE
MSCO
Overweight
Morgan Stanley says Myriad selloff on 23andMe approval a buying opportunity
Morgan Stanley analyst Steve Beuchaw said today's move lower in shares of Myriad Genetics "reflects confusion" on the regulatory backdrop for enetic tests and he believes the fact that 23andMe received an FDA approval yesterday for a consumer-facing pharmacogenetic screen is actually a positive for Myriad. Direct-to-consumer tests are not a substitute for clinical lab tests, as noted by the FDA, said Beuchaw, who believes uptake of consumer genomic tests, including their promotion by 23andMe, is a tailwind for Myriad and the category. He views the pullback as a buying opportunity and keeps an Overweight rating on Myriad Genetics shares.

TODAY'S FREE FLY STORIES

MORN

Morningstar

$126.83

-0.37 (-0.29%)

09:57
02/22/19
02/22
09:57
02/22/19
09:57
Earnings
Morningstar drops after admitting late 2018 market downturn hurt asset growth »

Morningstar last night…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$23.30

1.6 (7.37%)

, INTU

Intuit

$238.70

3.85 (1.64%)

09:55
02/22/19
02/22
09:55
02/22/19
09:55
Options
Early notable gainers among liquid option names on February 22nd »

Notable gainers among…

DLPH

Delphi Technologies

$23.30

1.6 (7.37%)

INTU

Intuit

$238.70

3.85 (1.64%)

EQT

EQT Corporation

$19.51

0.48 (2.52%)

CXO

Concho Resources

$106.07

2.38 (2.30%)

PXD

Pioneer Natural

$140.11

3.9 (2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 22

    May

  • 28

    May

ISRG

Intuitive Surgical

$555.58

5.59 (1.02%)

09:53
02/22/19
02/22
09:53
02/22/19
09:53
Technical Analysis
Technical Take: Intuitive Surgical has a large active bullish pattern »

On a 5-year weekly chart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$24.76

2 (8.79%)

09:51
02/22/19
02/22
09:51
02/22/19
09:51
Upgrade
iQIYI rating change  »

iQIYI upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MORN

Morningstar

$127.20

(0.00%)

09:50
02/22/19
02/22
09:50
02/22/19
09:50
Hot Stocks
Breaking Hot Stocks news story on Morningstar »

Morningstar trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$1.28

(0.00%)

09:50
02/22/19
02/22
09:50
02/22/19
09:50
Hot Stocks
Breaking Hot Stocks news story on Trillium Therapeutics »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

W

Wayfair

$143.50

26.36 (22.50%)

09:49
02/22/19
02/22
09:49
02/22/19
09:49
Recommendations
Wayfair analyst commentary  »

Wayfair's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

ASTE

Astec

$39.41

(0.00%)

, TEX

Terex

$35.65

0.06 (0.17%)

09:48
02/22/19
02/22
09:48
02/22/19
09:48
Recommendations
Astec ticks higher after Baird discusses possible takeover by Terex »

Terex (TEX) delaying its…

ASTE

Astec

$39.41

(0.00%)

TEX

Terex

$35.65

0.06 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$43.05

-4.22 (-8.93%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Nevro falls -9.2% »

Nevro is down -9.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASPN

Aspen Aerogels

$3.60

(0.00%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Aspen Aerogels falls -12.8% »

Aspen Aerogels is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPLO

Diplomat Pharmacy

$8.86

-4.6 (-34.18%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Diplomat Pharmacy falls -34.1% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

PAGS

PagSeguro Digital

$25.10

2.24 (9.80%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
PagSeguro Digital rises 11.1% »

PagSeguro Digital is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$145.68

28.54 (24.36%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Wayfair rises 24.5% »

Wayfair is up 24.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

BYD

Boyd Gaming

$31.30

3.02 (10.68%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Boyd Gaming rises 11.4% »

Boyd Gaming is up 11.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MORN

Morningstar

$127.20

(0.00%)

09:45
02/22/19
02/22
09:45
02/22/19
09:45
Hot Stocks
Breaking Hot Stocks news story on Morningstar »

Morningstar trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

09:44
02/22/19
02/22
09:44
02/22/19
09:44
On The Fly
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

TSLA

Tesla

$291.18

(0.00%)

GS

Goldman Sachs

$196.40

(0.00%)

IDEX

Ideanomics

$1.76

(0.00%)

AMD

AMD

$23.92

(0.00%)

NVDA

Nvidia

$155.76

(0.00%)

OSTK

Overstock.com

$20.00

(0.00%)

DPW

DPW Holdings

$0.09

(0.00%)

KODK

Kodak

$2.98

(0.00%)

RIOT

Riot Blockchain

$3.53

(0.00%)

TEUM

Pareteum

$3.76

(0.00%)

SRAX

Social Reality

$3.73

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 03

    Mar

  • 12

    Mar

  • 14

    Mar

  • 18

    Mar

  • 19

    Mar

LYB

LyondellBasell

$88.51

(0.00%)

09:41
02/22/19
02/22
09:41
02/22/19
09:41
Downgrade
LyondellBasell rating change  »

LyondellBasell downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$307,925.00

(0.00%)

, BRK.B

Berkshire Hathaway

$205.31

(0.00%)

09:40
02/22/19
02/22
09:40
02/22/19
09:40
Periodicals
Buffett's Berkshire set to lose about $3B from Kraft Heinz dive, CNBC says »

Warren Buffett's…

BRK.A

Berkshire Hathaway

$307,925.00

(0.00%)

BRK.B

Berkshire Hathaway

$205.31

(0.00%)

KHC

Kraft Heinz

$48.19

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBI

Pitney Bowes

$7.02

(0.00%)

, Z

Zillow

$35.03

(0.00%)

09:40
02/22/19
02/22
09:40
02/22/19
09:40
Options
Unusually active option classes on open February 22nd »

Unusual total active…

PBI

Pitney Bowes

$7.02

(0.00%)

Z

Zillow

$35.03

(0.00%)

DBX

Dropbox

$25.58

(0.00%)

W

Wayfair

$117.14

(0.00%)

ROKU

Roku

$51.47

(0.00%)

BIDU

Baidu

$171.72

(0.00%)

IQ

iQIYI

$22.76

(0.00%)

MDLZ

Mondelez

$48.39

(0.00%)

NEM

Newmont Mining

$35.39

(0.00%)

NIO

NIO Inc.

$7.62

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 03

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 20

    Mar

  • 25

    Mar

  • 28

    Mar

  • 28

    May

SID

CSN

09:38
02/22/19
02/22
09:38
02/22/19
09:38
Upgrade
CSN rating change  »

CSN upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

09:38
02/22/19
02/22
09:38
02/22/19
09:38
Downgrade
Kraft Heinz rating change  »

Kraft Heinz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FEYE

FireEye

$16.56

-0.105 (-0.63%)

09:37
02/22/19
02/22
09:37
02/22/19
09:37
Conference/Events
House Committee on Homeland Security to hold a hearing »

The Cybersecurity,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 04

    Mar

  • 05

    Mar

MGLN

Magellan Health

$70.81

-1.6 (-2.21%)

09:36
02/22/19
02/22
09:36
02/22/19
09:36
Hot Stocks
Magellan Health says will consider Starboard Value director nominees »

Magellan Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

EHTH

eHealth

$65.58

-0.28 (-0.43%)

09:36
02/22/19
02/22
09:36
02/22/19
09:36
Recommendations
eHealth analyst commentary  »

eHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

NXTM

NxStage Medical

$30.00

0.005 (0.02%)

, FMS

Fresenius Medical

$39.83

-0.06 (-0.15%)

09:33
02/22/19
02/22
09:33
02/22/19
09:33
Hot Stocks
NxStage Medical takeover by Fresenius Medical effective Feb. 21 »

NxStage Medical (NXTM)…

NXTM

NxStage Medical

$30.00

0.005 (0.02%)

FMS

Fresenius Medical

$39.83

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.